Figure 1.
Effect of vorinostat on histone hyperacetylation in vitro and in vivo. A: Immunoblotting for total and acetylated histone H3 in lysates from human umbilical vein endothelial cells exposed to dimethyl sulfoxide or 10 μmol/L vorinostat for 24 hours. B–E: IHC for acetylated histone H3 with C57BL/6 + vehicle (B), C57BL/6 + vorinostat (C), STZ-C57BL/6 + vehicle (D), and STZ-C57BL/6 + vorinostat (E). F: Quantitation of acetylated histone H3–positive nuclei. *P < 0.01 versus C57BL/6 + vehicle; **P < 0.01 versus STZ-C57BL/6 + vehicle.